PMID: 9650540Jul 3, 1998Paper

Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy

Journal of Clinical Pharmacology
G M LawsonN S Jiang

Abstract

As part of a clinical trial investigating the level of nicotine replacement with different doses of transdermal therapy for smoking cessation, urine excretion rates of nicotine and cotinine were measured in 70 subjects while they were actively smoking (baseline) and for 6 consecutive inpatient days while they were receiving transdermal nicotine therapy. Subjects were stratified according to baseline smoking rate as light (10-15 cigarettes per day), moderate (16-30 cigarettes per day), or heavy (>30 cigarettes per day) smokers and randomly assigned to a daily 24-hour patch delivering a transdermal nicotine dose of 0, 11, 22, or 44 mg. Steady-state excretion rates of nicotine and cotinine were attained in 2 and 3 days, respectively, at all doses and were independent of smoking rate. Percentage replacement of nicotine was calculated by dividing steady-state nicotine or cotinine excretion rates by their respective baseline excretion rates. Significant underreplacement occurred with the 11-mg/day dose, particularly in moderate and heavy smokers (<50%). At a dose of 22 mg/day, nicotine replacement was still <100% in the majority of subjects. Only at a dose of 44 mg/day did mean replacement exceed 100% regardless of baseline smoking r...Continue Reading

References

Jan 1, 1991·Drug Metabolism Reviews·G A Kyerematen, E S Vesell
Mar 1, 1990·Clinical Pharmacology and Therapeutics·S C MulliganJ G Kelly
Jul 21, 1983·The New England Journal of Medicine·N L BenowitzA L Osman
Nov 1, 1995·JAMA : the Journal of the American Medical Association·D E JorenbyT B Baker
Nov 1, 1995·JAMA : the Journal of the American Medical Association·L C DaleD R Schroeder
Nov 1, 1994·Clinical Pharmacology and Therapeutics·N L Benowitz, P Jacob
Jun 1, 1993·Drug and Alcohol Dependence·J E HenningfieldE D London

❮ Previous
Next ❯

Citations

Feb 14, 2004·Toxicology and Applied Pharmacology·Vivian Y ShinChi-Hin Cho
Aug 23, 2002·European Journal of Pharmacology·Vivian Y ShinChi H Cho
Feb 25, 2011·Annals of Surgical Oncology·Yung-Chang LienYu-Jia Chang
Nov 5, 2005·Journal of Clinical Periodontology·Yiyu Fang, Kathy K H Svoboda
Feb 20, 2004·Respiratory Medicine·Per GyllénIngemar Qvarfordt
Jan 16, 2004·Journal of Addictive Diseases·Lisa Sanderson CoxKenneth P Offord
Oct 31, 2000·Hospital Practice·J Meires, L Kuritzky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.